Elekta AB


Pressmeddelande   •   Aug 01, 2007 13:17 CEST

Investor information
Stockholm, Sweden, August 1, 2007

Elekta will release its 3 months report for fiscal year 2007/08 as follows:

• Report: Tuesday, September 25, 2007, around 1 pm CET

• Teleconference: Wednesday, September 26, 2007, at 3 pm CET

(Please note: due to the AGM on September 25, the teleconference will be held on the following day!)

Call in numbers and webcast details will be announced a few weeks prior to the teleconference or can be found on www.elekta.com/investors on the day of the teleconference.

Quiet period

According to the Board of Directors’ communication policy, Elekta shall observe a “quiet period” in relation to the financial markets prior to each interim and year-end report. The length of this quiet period should not be shorter than 30 days and not start earlier than the first day of the new quarter.

The quiet period means among other things that Elekta will decline any requests for investor or analysts meetings.

The quiet period in relation to the 3 months report for fiscal year 2007/08 will start on August 20, 2007.

Due to earlier commitments, Elekta will present at the Goldman Sachs European Medtech and Healthcare Services Conference in London on September 5. Slides from this presentation will be distributed on request.

6 months report 2007/08

Elekta will release its 6 months report for the fiscal year 2007/08 on December 12, 2007, around 1 pm, with a teleconference at 3 pm on the same day.

For further information, please contact:

Peter Ejemyr, Group VP Corporate Communications, Elekta AB
Tel: +46 733 611 000 (mobile), e-mail: peter.ejemyr@elekta.com

About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.

Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain disorders and Elekta Synergy® for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the world’s largest supplier of oncology software.

Elekta’s systems and solutions are used at over 4,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.

With approx. 2,000 employees, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.